- Home
- Your Messages
-
Smartest Doc
Test your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
We invite you to take the "Gynecologic oncology Quiz"
>> Live Leaderboard
New! PHYSICIAN REVIEW
Assess your general knowledge at the topic level with your personalized scorecard.
Thousands of multiple-choice questions pinpoint your areas of expertise and prep you for exams.
- Physician Jobs (511)
- More
- Other Specialty
Radiation Oncology News & Articles
Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Oncology
See All >> Messages include industry-sponsored communications and special communications from MDLinx-
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer -
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage -
Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls -
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools -
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
Articles
Latest Full Text Articles (48) Focus on Renal541 Reduced incidence of second solid tumors in survivors of childhood Hodgkin's lymphoma treated without radiation therapy Full Text Annals of Oncology, March 15, 2011
542 AIDS: A radiation oncologist's perspective Journal of Cancer Research and Therapeutics, March 15, 2011
543 Monte Carlo and experimental dosimetric study of the mHDR-v2 brachytherapy source Journal of Cancer Research and Therapeutics, March 15, 2011
544 Endolymphatic sac papillary carcinoma treated with surgery and post-operative intensity-modulated radiotherapy: A rare case report Journal of Cancer Research and Therapeutics, March 15, 2011
545 Dosimetric risk estimates of radiation-induced malignancies after intensity modulated radiotherapy Journal of Cancer Research and Therapeutics, March 15, 2011
546 Radiotherapy in rectal cancer: development, adequacy and radiotherapy utilisation rate. A comparative analysis with the most frequent tumour sites Clinical and Translational Oncology, March 15, 2011 Clinical Article
547 Is the N1c category of the new american joint committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy Cancer, March 14, 2011
548 The use of computer-aided manufacturing during the treatment of the edentulous mandible in an oral radiation therapy patient: clinical report The Journal of Prosthetic Dentistry, March 14, 2011
549 Current and Future Trends in Magnetic Resonance Imaging Assessments of the Response of Breast Tumors to Neoadjuvant Chemotherapy Journal of Oncology, March 11, 2011
550 Imaging, radiation oncology and randomised trials: Time for a change Journal of Medical Imaging and Radiation Oncology, March 11, 2011
551 Accelerated partial breast irradiation Journal of Surgical Oncology, March 11, 2011 Review Article
552
DNA Repair Biomarker Profiling of Head & Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death Following Radiotherapy Full Text
Clinical Cancer Research, March 10, 2011
Exclusive Author Commentary
553 Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography International Journal of Clinical Oncology, March 10, 2011
554 Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution’s experience Journal of Neuro-Oncology, March 10, 2011
555 Fatigue in prostate cancer patients treated with external beam radiotherapy: A prospective 5-year long-term patient-reported evaluation Journal of Cancer Research and Therapeutics, March 10, 2011
556 Advanced olfactory neuroblastoma treated with combined conventional and hypofractionated stereotactic radiotherapy Journal of Cancer Research and Therapeutics, March 10, 2011 Clinical Article
557
Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer
Cancer, March 9, 2011
Clinical Article
Exclusive Author Commentary
558 Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study Annals of Surgical Oncology, March 9, 2011
559 Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series Journal of Neuro-Oncology, March 7, 2011
560 Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy Cancer, March 2, 2011
Clinical Pearls in Oncology
- The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
- A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
- In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease
Highlights in Oncology
VEGFR-1 is a prognostic marker for HCC
As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.
Read the article summaryHCC risk increased in patients with AIDS
As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.
Read the article summaryRAB25 is a prognostic marker for ovarian cancer
As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.
Read the article summaryMost Popular Oncology Articles
Last month's top read Top Articles of 2012Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more
Other Topics in Oncology
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close